159 related articles for article (PubMed ID: 15053919)
1. Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase.
Oloumi A; McPhee T; Dedhar S
Biochim Biophys Acta; 2004 Apr; 1691(1):1-15. PubMed ID: 15053919
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
3. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.
Novak A; Hsu SC; Leung-Hagesteijn C; Radeva G; Papkoff J; Montesano R; Roskelley C; Grosschedl R; Dedhar S
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4374-9. PubMed ID: 9539744
[TBL] [Abstract][Full Text] [Related]
4. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of integrin-linked kinase activation in podocyte damage.
Teixeira Vde P; Blattner SM; Li M; Anders HJ; Cohen CD; Edenhofer I; Calvaresi N; Merkle M; Rastaldi MP; Kretzler M
Kidney Int; 2005 Feb; 67(2):514-23. PubMed ID: 15673299
[TBL] [Abstract][Full Text] [Related]
6. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
Persad S; Troussard AA; McPhee TR; Mulholland DJ; Dedhar S
J Cell Biol; 2001 Jun; 153(6):1161-74. PubMed ID: 11402061
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
Oloumi A; Syam S; Dedhar S
Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT).
Gil D; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Zwawa K; McCubrey JA; Laidler P
Adv Enzyme Regul; 2011; 51(1):195-207. PubMed ID: 21035499
[TBL] [Abstract][Full Text] [Related]
10. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
11. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
12. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner.
Gottardi CJ; Wong E; Gumbiner BM
J Cell Biol; 2001 May; 153(5):1049-60. PubMed ID: 11381089
[TBL] [Abstract][Full Text] [Related]
14. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
[TBL] [Abstract][Full Text] [Related]
15. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
[TBL] [Abstract][Full Text] [Related]
16. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
18. Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.
Naves MA; Requião-Moura LR; Soares MF; Silva-Júnior JA; Mastroianni-Kirsztajn G; Teixeira VP
J Nephrol; 2012; 25(3):401-9. PubMed ID: 21928230
[TBL] [Abstract][Full Text] [Related]
19. Requirement of protein kinase Calpha, extracellular matrix remodeling, and cell-matrix interaction for transforming growth factorbeta-regulated expression of E-cadherin and catenins.
Wang H; Chakrabarty S
J Cell Physiol; 2001 May; 187(2):188-95. PubMed ID: 11267998
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
